Stephanie Brooking, who began her career working on the Human Genome Project at the Wellcome Trust Sanger Institute, has been appointed head of product management at Evonetix Ltd, a UK synthetic biology company. In her new role she will help define a marketing strategy for the company’s gene synthesis products. Previously she was head of marketing and sales at Cambridge Epigenetix Ltd and global commercial director at Oxford Nanopore Technologies Ltd.
Evonetix announced the appointment on 14 January 2019.
Copyright 2019 Evernow Publishing Ltd.